The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)

Nakayama, Goro; Ishigure, Kiyoshi; Yokoyama, Hiroyuki; Uehara, Keisuke; Kojima, Hiroshi; Ishiyama, Akiharu; Hayashi, Naomi; Takano, Nao; Hattori, Norifumi; Kobayashi, Daisuke; Tanaka, Chie; Hayashi, Masamichi; Kanda, Mitsuro; Yamada, Suguru; Sugimoto, Hiroyuki; Koike, Masahiko; Fujiwara, Michitaka; Fujii, Tsutomu; Murotani, Kenta; Ando, Yuichi; Kodera, Yasuhiro

doi:10.1186/s12885-017-3245-1

BMC Cancer

Article metrics
Last updated: Thu, 25 Apr 2024 23:59:57 Z

The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)

Access & Citations

3375

Article Accesses
11

Web of Science
11

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com